MACROPHAGE PROCOAGULANTS

被引：0
|
作者：
EDWARDS, RL [1 ]
RICKLES, FR [1 ]
机构：
[1] VET ADM MED CTR, MED, NEWINGTON, CT 06111 USA
来源：
PROGRESS IN HEMOSTASIS AND THROMBOSIS | 1984年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：183 / 209
页数：27
相关论文
共 50 条
  • [31] Effect of snake venom procoagulants on snake plasma: implications for the coagulation cascade of snakes
    Joseph, JS
    Chung, MCM
    Mirtschin, PJ
    Kini, RM
    [J]. TOXICON, 2002, 40 (02) : 175 - 183
  • [32] HEREDITARY-DEFICIENCY OF ALL VITAMIN-K-DEPENDENT PROCOAGULANTS AND ANTICOAGULANTS
    BRENNER, B
    TAVORY, S
    ZIVELIN, A
    TATARSKY, I
    SELIGSOHN, U
    [J]. THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 295 - 295
  • [33] HEREDITARY-DEFICIENCY OF ALL VITAMIN-K-DEPENDENT PROCOAGULANTS AND ANTICOAGULANTS
    BRENNER, B
    TAVORI, S
    ZIVELIN, A
    KELLER, CB
    SUTTIE, JW
    TATARSKY, I
    SELIGSOHN, U
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (04) : 537 - 542
  • [34] Use of three procoagulants in improving bleeding outcomes in the warfarin patient with intracranial hemorrhage
    DeLoughery, Emma P.
    DeLoughery, Thomas G.
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (08) : 612 - 616
  • [35] Hereditary deficiency of all vitamin-K-dependent procoagulants and anticoagulants in a young Tunisian
    Houissa-Kastally, R
    Oueslati, A
    Gharbi, Y
    Maherzi, A
    Bousnina, S
    Arkam, R
    Guillaumont, M
    Gouin-Thibault, I
    Samama, MM
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 342 - 342
  • [36] Analysis of the Safety Profile of Commonly Used Procoagulants Using the FDA Adverse Event Reporting System
    Deloughery, Emma P.
    Shatzel, Joseph J.
    [J]. BLOOD, 2018, 132
  • [37] CANCER PROCOAGULANTS PROMOTE TUMOR GROWTH AND ANGIOGENESIS IN BREAST CANCER PROGRESSION; AN IN VIVO BIOMARKER STUDY
    Tetik, S.
    Ergun, S.
    Sahin, S.
    Erdogan, N.
    [J]. THROMBOSIS RESEARCH, 2016, 141 : S1 - S1
  • [38] Hemostatic Status in Liver Transplantation: Association Between Preoperative Procoagulants/Anticoagulants and Postoperative Hemorrhaging/Thrombosis
    Akamatsu, Nobuhisa
    Sugawara, Yasuhiko
    Nakazawa, Akiko
    Nishioka, Yujiro
    Kaneko, Junichi
    Aoki, Taku
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    [J]. LIVER TRANSPLANTATION, 2015, 21 (02) : 258 - 265
  • [39] Fibrin formation induced by tumor procoagulants enhances urokinase activity produced by mammary carcinoma cells
    Alonso, DF
    de Lorenzo, MS
    Tejera, AM
    Gomez, DE
    [J]. ONCOLOGY REPORTS, 1998, 5 (01) : 209 - 212
  • [40] MONOCYTE TISSUE FACTOR EXPRESSION - A RAPID AND SENSITIVE FLOW-CYTOMETRIC METHOD FOR ASSESSING CELLULAR PROCOAGULANTS
    LEATHAM, E
    BATH, P
    TOOZE, J
    MARTIN, D
    TUDDENHAM, E
    CAMM, AJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A40 - A40
12345